Belite Bio BLTE
NASDAQ BLTE
$193.81 +22.72 (+13.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Belite Bio (BLTE) Price to Book (2022 - 2026)

Analysis

Belite Bio (BLTE) Price to Book (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Belite Bio 6.44 Bn 6.44 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.80
Mar 31, 2026 7.88
Dec 31, 2025 8.17
Sep 30, 2025 8.59
Jun 30, 2025 12.25
Mar 31, 2025 13.33
Dec 31, 2024 13.77
Sep 30, 2024 12.18
Jun 30, 2024 11.62
Mar 31, 2024 11.59
Dec 31, 2023 14.75
Sep 30, 2023 12.05
Jun 30, 2023 5.12
Mar 31, 2023 16.98
Dec 31, 2022 14.51
Jun 30, 2022 6.45